DELAYED GRAFT FUNCTION
Clinical trials for DELAYED GRAFT FUNCTION explained in plain language.
Never miss a new study
Get alerted when new DELAYED GRAFT FUNCTION trials appear
Sign up with your email to follow new studies for DELAYED GRAFT FUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to kickstart transplanted kidneys faster
Disease control Recruiting nowThis phase 3 trial tests whether ravulizumab, given intravenously, can reduce the severity of delayed graft function (DGF) in adults at high risk after kidney transplant. DGF is when the new kidney is slow to start working, often requiring dialysis. The study will compare ravuliz…
Matched conditions: DELAYED GRAFT FUNCTION
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo aims to protect kidney transplants from early failure
Disease control Recruiting nowThis study tests whether adding terlipressin to standard care helps maintain stable blood pressure during kidney transplant surgery. Researchers will compare two groups of 150 adults: one receiving terlipressin plus dobutamine, the other dobutamine alone. The main goal is to see …
Matched conditions: DELAYED GRAFT FUNCTION
Phase: NA • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a 2-Day infusion save transplanted kidneys from early damage?
Disease control Recruiting nowThis study tests whether a drug called treprostinil can help prevent injury to a new kidney during transplant surgery. About 20 adults receiving a deceased donor kidney will get the drug through an IV for two days, starting just before surgery. The goal is to see if it improves b…
Matched conditions: DELAYED GRAFT FUNCTION
Phase: PHASE1, PHASE2 • Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a common acid blocker save transplanted kidneys?
Disease control Recruiting nowThis early-phase trial tests whether a stomach acid drug called vonoprazan fumarate can reduce delayed graft function, a common complication where a new kidney doesn't work right away. About 47 first-time kidney transplant recipients will take the drug for seven days after surger…
Matched conditions: DELAYED GRAFT FUNCTION
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC